Array
(
[direction] => 1
[market_status] => green
)Chirag Talati, pharma analyst, Espirito Santo Securities says the RBI's move to boost the Indian currency by asking exporters to convert 50% of their foreign exchange holdings into rupees will not have a significant impact on pharma companies.
first published: May 10, 2012 02:56 pm
A collection of the most-viewed Moneycontrol videos.

Trump Claims Iran Will Never Shut Hormuz Again, Big Statement Raises Global Questions

AMIT SHAH FULL SPEECH: Amit Shah Addresses Lok Sabha on Reservation, Delimitation & Representation

Live: Broader markets outperform this week; Metal, realty top sectoral plays | Closing Bell

Trump Signals Major Breakthrough In Iran Deal, May Visit Islamabad Soon
You are already a Moneycontrol Pro user.


